nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—Sciatica—Telbivudine—hepatitis B	0.0467	0.0467	CcSEcCtD
Risedronate—Abdominal pain lower—Telbivudine—hepatitis B	0.042	0.042	CcSEcCtD
Risedronate—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.0273	0.0273	CcSEcCtD
Risedronate—Fracture—Adefovir Dipivoxil—hepatitis B	0.0273	0.0273	CcSEcCtD
Risedronate—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0173	0.0173	CcSEcCtD
Risedronate—Bone pain—Adefovir Dipivoxil—hepatitis B	0.0166	0.0166	CcSEcCtD
Risedronate—Neck pain—Telbivudine—hepatitis B	0.0135	0.0135	CcSEcCtD
Risedronate—Musculoskeletal pain—Telbivudine—hepatitis B	0.0135	0.0135	CcSEcCtD
Risedronate—Influenza like illness—Telbivudine—hepatitis B	0.013	0.013	CcSEcCtD
Risedronate—Abdominal pain upper—Entecavir—hepatitis B	0.0108	0.0108	CcSEcCtD
Risedronate—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.0106	0.0106	CcSEcCtD
Risedronate—Amblyopia—Lamivudine—hepatitis B	0.00975	0.00975	CcSEcCtD
Risedronate—Pain in extremity—Telbivudine—hepatitis B	0.00969	0.00969	CcSEcCtD
Risedronate—Upper respiratory tract infection—Entecavir—hepatitis B	0.00948	0.00948	CcSEcCtD
Risedronate—Abdominal pain upper—Telbivudine—hepatitis B	0.00885	0.00885	CcSEcCtD
Risedronate—Nasopharyngitis—Telbivudine—hepatitis B	0.00867	0.00867	CcSEcCtD
Risedronate—Hepatobiliary disease—Entecavir—hepatitis B	0.0086	0.0086	CcSEcCtD
Risedronate—Gastritis—Telbivudine—hepatitis B	0.00858	0.00858	CcSEcCtD
Risedronate—Muscular weakness—Telbivudine—hepatitis B	0.00855	0.00855	CcSEcCtD
Risedronate—Abdominal distension—Telbivudine—hepatitis B	0.00844	0.00844	CcSEcCtD
Risedronate—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00839	0.00839	CcSEcCtD
Risedronate—Influenza—Telbivudine—hepatitis B	0.00838	0.00838	CcSEcCtD
Risedronate—Bone disorder—Lamivudine—hepatitis B	0.00833	0.00833	CcSEcCtD
Risedronate—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00832	0.00832	CcSEcCtD
Risedronate—Oedema peripheral—Entecavir—hepatitis B	0.00804	0.00804	CcSEcCtD
Risedronate—Abdominal discomfort—Telbivudine—hepatitis B	0.00803	0.00803	CcSEcCtD
Risedronate—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00796	0.00796	CcSEcCtD
Risedronate—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00791	0.00791	CcSEcCtD
Risedronate—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00787	0.00787	CcSEcCtD
Risedronate—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00783	0.00783	CcSEcCtD
Risedronate—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00781	0.00781	CcSEcCtD
Risedronate—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00779	0.00779	CcSEcCtD
Risedronate—Inflammation—Lamivudine—hepatitis B	0.00776	0.00776	CcSEcCtD
Risedronate—Musculoskeletal pain—Lamivudine—hepatitis B	0.00762	0.00762	CcSEcCtD
Risedronate—Eructation—Lamivudine—hepatitis B	0.00739	0.00739	CcSEcCtD
Risedronate—Immune system disorder—Entecavir—hepatitis B	0.00737	0.00737	CcSEcCtD
Risedronate—Mental disorder—Entecavir—hepatitis B	0.00715	0.00715	CcSEcCtD
Risedronate—Malnutrition—Entecavir—hepatitis B	0.00711	0.00711	CcSEcCtD
Risedronate—Hepatobiliary disease—Telbivudine—hepatitis B	0.00707	0.00707	CcSEcCtD
Risedronate—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00693	0.00693	CcSEcCtD
Risedronate—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00683	0.00683	CcSEcCtD
Risedronate—Back pain—Adefovir Dipivoxil—hepatitis B	0.00671	0.00671	CcSEcCtD
Risedronate—Pharyngitis—Telbivudine—hepatitis B	0.00666	0.00666	CcSEcCtD
Risedronate—Connective tissue disorder—Telbivudine—hepatitis B	0.00659	0.00659	CcSEcCtD
Risedronate—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00641	0.00641	CcSEcCtD
Risedronate—Gastroenteritis—Lamivudine—hepatitis B	0.00616	0.00616	CcSEcCtD
Risedronate—Cough—Adefovir Dipivoxil—hepatitis B	0.00605	0.00605	CcSEcCtD
Risedronate—Mediastinal disorder—Telbivudine—hepatitis B	0.00604	0.00604	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00601	0.00601	CcSEcCtD
Risedronate—Injury—Lamivudine—hepatitis B	0.00594	0.00594	CcSEcCtD
Risedronate—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0059	0.0059	CcSEcCtD
Risedronate—Chest pain—Adefovir Dipivoxil—hepatitis B	0.0059	0.0059	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00586	0.00586	CcSEcCtD
Risedronate—Malnutrition—Telbivudine—hepatitis B	0.00584	0.00584	CcSEcCtD
Risedronate—Infection—Entecavir—hepatitis B	0.00576	0.00576	CcSEcCtD
Risedronate—Nervous system disorder—Entecavir—hepatitis B	0.00569	0.00569	CcSEcCtD
Risedronate—Back pain—Telbivudine—hepatitis B	0.00565	0.00565	CcSEcCtD
Risedronate—Skin disorder—Entecavir—hepatitis B	0.00563	0.00563	CcSEcCtD
Risedronate—Muscle spasms—Telbivudine—hepatitis B	0.00561	0.00561	CcSEcCtD
Risedronate—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00555	0.00555	CcSEcCtD
Risedronate—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0055	0.0055	CcSEcCtD
Risedronate—Insomnia—Entecavir—hepatitis B	0.00525	0.00525	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00516	0.00516	CcSEcCtD
Risedronate—Dyspepsia—Entecavir—hepatitis B	0.00511	0.00511	CcSEcCtD
Risedronate—Cough—Telbivudine—hepatitis B	0.00509	0.00509	CcSEcCtD
Risedronate—Liver function test abnormal—Lamivudine—hepatitis B	0.00504	0.00504	CcSEcCtD
Risedronate—Gastrointestinal disorder—Entecavir—hepatitis B	0.00501	0.00501	CcSEcCtD
Risedronate—Fatigue—Entecavir—hepatitis B	0.005	0.005	CcSEcCtD
Risedronate—Abdominal pain upper—Lamivudine—hepatitis B	0.00499	0.00499	CcSEcCtD
Risedronate—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00498	0.00498	CcSEcCtD
Risedronate—Arthralgia—Telbivudine—hepatitis B	0.00497	0.00497	CcSEcCtD
Risedronate—Chest pain—Telbivudine—hepatitis B	0.00497	0.00497	CcSEcCtD
Risedronate—Myalgia—Telbivudine—hepatitis B	0.00497	0.00497	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00494	0.00494	CcSEcCtD
Risedronate—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00489	0.00489	CcSEcCtD
Risedronate—Nasopharyngitis—Lamivudine—hepatitis B	0.00489	0.00489	CcSEcCtD
Risedronate—Muscular weakness—Lamivudine—hepatitis B	0.00482	0.00482	CcSEcCtD
Risedronate—Abdominal distension—Lamivudine—hepatitis B	0.00475	0.00475	CcSEcCtD
Risedronate—Gastrointestinal pain—Entecavir—hepatitis B	0.00474	0.00474	CcSEcCtD
Risedronate—Influenza—Lamivudine—hepatitis B	0.00472	0.00472	CcSEcCtD
Risedronate—Nervous system disorder—Telbivudine—hepatitis B	0.00467	0.00467	CcSEcCtD
Risedronate—Skin disorder—Telbivudine—hepatitis B	0.00463	0.00463	CcSEcCtD
Risedronate—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00463	0.00463	CcSEcCtD
Risedronate—Body temperature increased—Entecavir—hepatitis B	0.00459	0.00459	CcSEcCtD
Risedronate—Abdominal pain—Entecavir—hepatitis B	0.00459	0.00459	CcSEcCtD
Risedronate—Bronchitis—Lamivudine—hepatitis B	0.00454	0.00454	CcSEcCtD
Risedronate—Abdominal discomfort—Lamivudine—hepatitis B	0.00453	0.00453	CcSEcCtD
Risedronate—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00447	0.00447	CcSEcCtD
Risedronate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00447	0.00447	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00434	0.00434	CcSEcCtD
Risedronate—Insomnia—Telbivudine—hepatitis B	0.00431	0.00431	CcSEcCtD
Risedronate—Paraesthesia—Telbivudine—hepatitis B	0.00428	0.00428	CcSEcCtD
Risedronate—Depression—Lamivudine—hepatitis B	0.0042	0.0042	CcSEcCtD
Risedronate—Dyspepsia—Telbivudine—hepatitis B	0.00419	0.00419	CcSEcCtD
Risedronate—Asthenia—Entecavir—hepatitis B	0.00416	0.00416	CcSEcCtD
Risedronate—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00411	0.00411	CcSEcCtD
Risedronate—Fatigue—Telbivudine—hepatitis B	0.00411	0.00411	CcSEcCtD
Risedronate—Pain—Telbivudine—hepatitis B	0.00407	0.00407	CcSEcCtD
Risedronate—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00406	0.00406	CcSEcCtD
Risedronate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.004	0.004	CcSEcCtD
Risedronate—Hepatobiliary disease—Lamivudine—hepatitis B	0.00398	0.00398	CcSEcCtD
Risedronate—Diarrhoea—Entecavir—hepatitis B	0.00397	0.00397	CcSEcCtD
Risedronate—Sinusitis—Lamivudine—hepatitis B	0.00395	0.00395	CcSEcCtD
Risedronate—Gastrointestinal pain—Telbivudine—hepatitis B	0.0039	0.0039	CcSEcCtD
Risedronate—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00387	0.00387	CcSEcCtD
Risedronate—Dizziness—Entecavir—hepatitis B	0.00384	0.00384	CcSEcCtD
Risedronate—Rhinitis—Lamivudine—hepatitis B	0.00379	0.00379	CcSEcCtD
Risedronate—Body temperature increased—Telbivudine—hepatitis B	0.00377	0.00377	CcSEcCtD
Risedronate—Abdominal pain—Telbivudine—hepatitis B	0.00377	0.00377	CcSEcCtD
Risedronate—Pharyngitis—Lamivudine—hepatitis B	0.00375	0.00375	CcSEcCtD
Risedronate—Connective tissue disorder—Lamivudine—hepatitis B	0.00371	0.00371	CcSEcCtD
Risedronate—Vomiting—Entecavir—hepatitis B	0.00369	0.00369	CcSEcCtD
Risedronate—Rash—Entecavir—hepatitis B	0.00366	0.00366	CcSEcCtD
Risedronate—Dermatitis—Entecavir—hepatitis B	0.00365	0.00365	CcSEcCtD
Risedronate—Headache—Entecavir—hepatitis B	0.00363	0.00363	CcSEcCtD
Risedronate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.0036	0.0036	CcSEcCtD
Risedronate—Rash—Adefovir Dipivoxil—hepatitis B	0.00357	0.00357	CcSEcCtD
Risedronate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00357	0.00357	CcSEcCtD
Risedronate—Headache—Adefovir Dipivoxil—hepatitis B	0.00355	0.00355	CcSEcCtD
Risedronate—Nausea—Entecavir—hepatitis B	0.00345	0.00345	CcSEcCtD
Risedronate—Asthenia—Telbivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Risedronate—Immune system disorder—Lamivudine—hepatitis B	0.00341	0.00341	CcSEcCtD
Risedronate—Mediastinal disorder—Lamivudine—hepatitis B	0.00341	0.00341	CcSEcCtD
Risedronate—Pruritus—Telbivudine—hepatitis B	0.00337	0.00337	CcSEcCtD
Risedronate—Nausea—Adefovir Dipivoxil—hepatitis B	0.00336	0.00336	CcSEcCtD
Risedronate—Malnutrition—Lamivudine—hepatitis B	0.00329	0.00329	CcSEcCtD
Risedronate—Diarrhoea—Telbivudine—hepatitis B	0.00326	0.00326	CcSEcCtD
Risedronate—Flatulence—Lamivudine—hepatitis B	0.00324	0.00324	CcSEcCtD
Risedronate—Back pain—Lamivudine—hepatitis B	0.00318	0.00318	CcSEcCtD
Risedronate—Muscle spasms—Lamivudine—hepatitis B	0.00316	0.00316	CcSEcCtD
Risedronate—Dizziness—Telbivudine—hepatitis B	0.00315	0.00315	CcSEcCtD
Risedronate—Anaemia—Lamivudine—hepatitis B	0.00304	0.00304	CcSEcCtD
Risedronate—Vomiting—Telbivudine—hepatitis B	0.00303	0.00303	CcSEcCtD
Risedronate—Angioedema—Lamivudine—hepatitis B	0.00301	0.00301	CcSEcCtD
Risedronate—Rash—Telbivudine—hepatitis B	0.003	0.003	CcSEcCtD
Risedronate—Dermatitis—Telbivudine—hepatitis B	0.003	0.003	CcSEcCtD
Risedronate—Headache—Telbivudine—hepatitis B	0.00299	0.00299	CcSEcCtD
Risedronate—Vertigo—Lamivudine—hepatitis B	0.00296	0.00296	CcSEcCtD
Risedronate—Syncope—Lamivudine—hepatitis B	0.00295	0.00295	CcSEcCtD
Risedronate—Loss of consciousness—Lamivudine—hepatitis B	0.00289	0.00289	CcSEcCtD
Risedronate—Cough—Lamivudine—hepatitis B	0.00287	0.00287	CcSEcCtD
Risedronate—Nausea—Telbivudine—hepatitis B	0.00283	0.00283	CcSEcCtD
Risedronate—Chest pain—Lamivudine—hepatitis B	0.0028	0.0028	CcSEcCtD
Risedronate—Myalgia—Lamivudine—hepatitis B	0.0028	0.0028	CcSEcCtD
Risedronate—Arthralgia—Lamivudine—hepatitis B	0.0028	0.0028	CcSEcCtD
Risedronate—Anxiety—Lamivudine—hepatitis B	0.00279	0.00279	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00278	0.00278	CcSEcCtD
Risedronate—Dry mouth—Lamivudine—hepatitis B	0.00274	0.00274	CcSEcCtD
Risedronate—Infection—Lamivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Risedronate—Shock—Lamivudine—hepatitis B	0.00264	0.00264	CcSEcCtD
Risedronate—Nervous system disorder—Lamivudine—hepatitis B	0.00263	0.00263	CcSEcCtD
Risedronate—Skin disorder—Lamivudine—hepatitis B	0.00261	0.00261	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00245	0.00245	CcSEcCtD
Risedronate—Insomnia—Lamivudine—hepatitis B	0.00243	0.00243	CcSEcCtD
Risedronate—Paraesthesia—Lamivudine—hepatitis B	0.00241	0.00241	CcSEcCtD
Risedronate—Dyspnoea—Lamivudine—hepatitis B	0.00239	0.00239	CcSEcCtD
Risedronate—Dyspepsia—Lamivudine—hepatitis B	0.00236	0.00236	CcSEcCtD
Risedronate—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00232	0.00232	CcSEcCtD
Risedronate—Fatigue—Lamivudine—hepatitis B	0.00232	0.00232	CcSEcCtD
Risedronate—Constipation—Lamivudine—hepatitis B	0.0023	0.0023	CcSEcCtD
Risedronate—Pain—Lamivudine—hepatitis B	0.0023	0.0023	CcSEcCtD
Risedronate—Gastrointestinal pain—Lamivudine—hepatitis B	0.0022	0.0022	CcSEcCtD
Risedronate—Urticaria—Lamivudine—hepatitis B	0.00213	0.00213	CcSEcCtD
Risedronate—Abdominal pain—Lamivudine—hepatitis B	0.00212	0.00212	CcSEcCtD
Risedronate—Body temperature increased—Lamivudine—hepatitis B	0.00212	0.00212	CcSEcCtD
Risedronate—Hypersensitivity—Lamivudine—hepatitis B	0.00198	0.00198	CcSEcCtD
Risedronate—Asthenia—Lamivudine—hepatitis B	0.00193	0.00193	CcSEcCtD
Risedronate—Pruritus—Lamivudine—hepatitis B	0.0019	0.0019	CcSEcCtD
Risedronate—Diarrhoea—Lamivudine—hepatitis B	0.00184	0.00184	CcSEcCtD
Risedronate—Dizziness—Lamivudine—hepatitis B	0.00178	0.00178	CcSEcCtD
Risedronate—Vomiting—Lamivudine—hepatitis B	0.00171	0.00171	CcSEcCtD
Risedronate—Rash—Lamivudine—hepatitis B	0.00169	0.00169	CcSEcCtD
Risedronate—Dermatitis—Lamivudine—hepatitis B	0.00169	0.00169	CcSEcCtD
Risedronate—Headache—Lamivudine—hepatitis B	0.00168	0.00168	CcSEcCtD
Risedronate—Nausea—Lamivudine—hepatitis B	0.0016	0.0016	CcSEcCtD
